1. Amin P, Awal S, Vigneron S, Roque S, Mechali
F, Labbé JC, et al. PP2A-B55: substrates and reg-
ulators in the control of cellular functions. Onco-
gene. 2022; 41(1):1-4.
2. Günther V, Lindert U, Schaffner W. The taste
of heavy metals: gene regulation by MTF-1. Bio-
chim Biophys Acta Mol Cell Res. 2012;
1823(9):1416-25.
3. Wang Y, Wimmer U, Lichtlen P, Inderbitzin D,
Stieger B, Meier PJ, et al. Metal‐responsive tran-
scription factor‐1 (MTF‐1) is essential for embry-
onic liver development and heavy metal detoxifi-
cation in the adult liver. The FASEB journal. 2004;
18(10):1071-9.
4. Schwabe RF, Brenner DA. Mechanisms of Liver
Injury. I. TNF-α-induced liver injury: role of IKK,
JNK, and ROS pathways. Am J Physiol Gastroin-
test Liver Physiol. 2006; 290:G583–G589.
5. Reynhout S, Janssens V. Physiologic functions of
PP2A: Lessons from genetically modified mice.
Biochim Biophys Acta Mol Cell Res. 2019;
1866(1):31-50.
6. Fowle H, Zhao Z, Graña X. PP2A holoenzymes,
substrate specificity driving cellular functions and
deregulation in cancer. Adv Cancer Res. 2019;
144:55-93.
7. Rice LM, Donigan M, Yang M, Liu W, Pandya
D, Joseph BK, et al. Protein phosphatase 2A
(PP2A) regulates low density lipoprotein uptake
through regulating sterol response element-bind-
ing protein-2 (SREBP-2) DNA binding. J Biol
Chem. 2014; 289(24):17268-79.
8. Ivovič D, Kabelikova P, Jurkovičová D. Unrav-
eling the complexity: A comprehensive analysis of
the PP2A in cancer and its potential for novel tar-
geted therapies. Neoplasma. 2023; 70(4): 485-499.
9. Lichtlen P, Schaffner W. Putting its fingers on
stressful situations: the heavy metal‐regulatory
transcription factor MTF‐1. Bioessays. 2001;
23(11):1010-17. DOI: 10.1002/bies.1146.
10. Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M,
Gil A. Mechanisms of action of probiotics. Adv
nutr. 2019; 10(suppl_1):S49-66. DOI: 10.1093/ad-
vances/nmy063.
11. Kern L, Tofield A, Frame J, Elinav E. Next-gen-
eration probiotics: an outlook into current applica-
tions and future developments. Nat Rev Microbiol.
2026; 8:1-20.
12. Qi Y, Li L, Wei Y, Ma F. PP2A as a potential
therapeutic target for breast cancer: Current in-
sights and future perspectives. Biomed Pharma-
cother. 2024; 173:116398.
13. Şirin S. Lactic acid bacteria-derived exopolysac-
charides mitigate the oxidative response via the
NRF2-KEAP1 pathway in PC12 cells. Curr Issues
Mol Bio. 2023; 45(10):8071-90.
14. Zhang X, Xia Y, Ji F. Lactobacillaceae in Acute
and Chronic Liver Diseases: From Microbiota
Modulation to Therapeutic Potential. Probiotics
Antimicrob Proteins. 2026; 30:1-20.
15. Markowiak P, Śliżewska K. Effects of probiot-
ics, prebiotics, and synbiotics on human health.
Nutrients. 2017; 9(9):1021.
16. Darbandi A, Navidifar T, Koupaei M, Afifirad
R, Nezhad RA, Emamie A, et al. The effect of the
combination of probiotics and heavy metals from
various aspects in humans: a systematic review of
clinical trial studies. Health Sci Rep. 2025;
8(3):e70521.
17. Rezazadegan M, Forootani B, Hoveyda Y, Re-
zazadegan N, Amani R. Major heavy metals and
human gut microbiota composition: a systematic
review with nutritional approach. J Health Popul
Nutr. 2025; 44(1):21-37.
18. Hill C, Guarner F, Reid G, Gibson GR, Meren-
stein DJ, Pot B, et al. Expert consensus document.
The International Scientific Association for Probi-
otics and Prebiotics consensus statement on the
scope and appropriate use of the term probiotic.
Nat Rev Gastroenterol Hepatol. 2014;11(8):506-
14.
19. Kim BK, Lee IO, Tan PL, Eor JY, Hwang JK,
Kim SH. Protective effect of Lactobacillus fer-
mentum LA12 in an alcohol-induced rat model of
alcoholic steatohepatitis. Korean J Food Sci Anim
Resour. 2017; 37(6):931-39.
20. (Younes M, Aggett P, Aguilar F, Crebelli R,
Dusemund B, Filipič M, et al. Re‐evaluation of
stannous chloride (E 512) as food additive. EFSA
Journal. 2018;16(6):e05295.
21. Festing MF, Altman DG. Guidelines for the de-
sign and statistical analysis of experiments using
laboratory animals. ILAR Journal.
2002;43(4):244-58.
22. Langley G, Broadhead C, Bottrill K, Combes R,
Ewbank R. Accessing information on the reduc-
tion, refinement and replacement of animal exper-
iments: Report and recommendations of a Focus
on Alternatives Workshop. Altern Lab Anim.
1999;27(2):239-45.
23. De Groot AP, Feron VJ, Til HP. Short-term tox-
icity studies on some salts and oxides of tin in rats.
Food Cosmet Toxicol. 1973;11(1):19-30.
24. Yamaguchi M, Saito R, Okada S. Dose-effect of
inorganic tin on biochemical indices in rats. Toxi-
col. 1980;16(3):267-73.
25. Saeedi BJ, Liu KH, Owens JA, Hunter-Chang
S, Camacho MC, Eboka RU, et al. Gut-resident
lactobacilli activate hepatic Nrf2 and protect
against oxidative liver injury. Cell Metab.
2020;31(5):956-68.
26. Haanen III TJ, O'Connor CM, Narla G. Biased
holoenzyme assembly of protein phosphatase 2A
(PP2A): From cancer to small molecules. J Biol
Chem. 2022;298(12):102656.

27. Johnson H, Narayan S, Sharma AK. Altering
phosphorylation in cancer through PP2A modifi-
ers. Cancer Cell Int. 2024;24(1):11-28.
28. Chen L, Guo P, Li W, Jiang X, Zhao Q, Li D, et
al. Protein phosphatase 2A regulates cytotoxicity
and drug resistance by dephosphorylating AHR
and MDR1. J Biol Chem. 2022;298(5):101918.
29. Chen Y, Liu H, An T, Wu Q, Zhang H, Loor JJ,
et al. Lactobacillus intestinalis/Lactobacillus
rhamnosus protects against AFB1-induced liver
damage: involvement of intestinal mucosal barrier.
One Health Adv. 2023;1(1):24-36. DOI:
10.1186/s44280-023-00023-x.
30. Duan H, Yu L, Tian F, Zhai Q, Fan L, Chen W.
Gut microbiota: a target for heavy metal toxicity
and a probiotic protective strategy. Sci Total Envi-
ron. 2020;742:140429.
31. Hsu CL, Schnabl B. The gut–liver axis and gut
microbiota in health and liver disease. Nat Rev Mi-
crobiol. 2023 ;21(11):719-33. DOI:
10.1038/s41579-023-00904-3.
32. Pabst O, Hornef MW, Schaap FG, Cerovic V,
Clavel T, Bruns T. Gut–liver axis: barriers and
functional circuits. Nat Rev Gastroenterol Hepa-
tol. 2023;20(7):447-61.